Risk factors for outcome in refractory acute myeloid leukemia patients treated with a combination of fludarabine, cytarabine, and amsacrine followed by a reduced-intensity conditioning and allogeneic stem cell transplantation

被引：0
|
作者：
Christian Pfrepper
Anne Klink
Gerhard Behre
Thomas Schenk
Georg-Nikolaus Franke
Madlen Jentzsch
Sebastian Schwind
Haifa-Kathrin Al-Ali
Andreas Hochhaus
Dietger Niederwieser
Herbert Gottfried Sayer
机构：
[1] Universitätsklinikum Leipzig,Abteilung für Hämatologie, Internistische Onkologie
[2] Universitätsklinikum Jena,Klinik für Innere Medizin II, Abteilung für Hämatologie und Internistische Onkologie
[3] HELIOS-Klinikum Erfurt,4. Medizinische Klinik (Hämatologie, internistische Onkologie und Hämostaseologie)
来源：
Journal of Cancer Research and Clinical Oncology | 2016年 / 142卷
关键词：
Allogeneic stem cell transplantation; Refractory acute myeloid leukemia; FLAMSA-RIC; Risk factors after allogeneic HCT, donor lymphocytic infusions; DLI; Reduced-intensity conditioning;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：317 / 324
页数：7
相关论文
共 50 条
  • [1] Risk factors for outcome in refractory acute myeloid leukemia patients treated with a combination of fludarabine, cytarabine, and amsacrine followed by a reduced-intensity conditioning and allogeneic stem cell transplantation
    Pfrepper, Christian
    Klink, Anne
    Behre, Gerhard
    Schenk, Thomas
    Franke, Georg-Nikolaus
    Jentzsch, Madlen
    Schwind, Sebastian
    Al-Ali, Haifa-Kathrin
    Hochhaus, Andreas
    Niederwieser, Dietger
    Sayer, Herbert Gottfried
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2016, 142 (01) : 317 - 324
  • [2] Combination of fludarabine, amsacrine, and cytarabine followed by reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with high-risk acute myeloid leukemia
    Krejci, Marta
    Doubek, Michael
    Dusek, Jaroslav
    Brychtova, Yvona
    Racil, Zdenek
    Navratil, Milan
    Tomiska, Miroslav
    Horky, Ondrej
    Pospisilova, Sarka
    Mayer, Jiri
    ANNALS OF HEMATOLOGY, 2013, 92 (10) : 1397 - 1403
  • [3] Combination of fludarabine, amsacrine, and cytarabine followed by reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with high-risk acute myeloid leukemia
    Marta Krejci
    Michael Doubek
    Jaroslav Dusek
    Yvona Brychtova
    Zdenek Racil
    Milan Navratil
    Miroslav Tomiska
    Ondrej Horky
    Sarka Pospisilova
    Jiri Mayer
    Annals of Hematology, 2013, 92 : 1397 - 1403
  • [4] Combination of fludarabine, amsacrine and cytarabine followed by reduced-intensity conditioning and allogeneic haematopoietic stem cell transplantation in 60 patients with high-risk acute myeloid leukaemia
    Krejci, M.
    Doubek, M.
    Racil, Z.
    Brychtova, Y.
    Koristek, Z.
    Navratil, M.
    Tomiska, M.
    Horky, O.
    Sandecka, V.
    Dusek, L.
    Mayer, J.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S393 - S393
  • [5] COMBINATION OF FLUDARABINE, AMSACRINE AND CYTARABINE FOLLOWED BY REDUCED-INTENSITY CONDITIONING AND ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN 15 PATIENTS WITH MYELOFIBROSIS
    Krejci, M.
    Doubek, M.
    Brychtova, Y.
    Tomiska, M.
    Horky, O.
    Sandecka, V.
    Mayer, J.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S193 - S194
  • [6] Reduced-intensity conditioning followed by allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia
    Ehninger, G.
    Platzbecker, U.
    Bornhaaeuser, M.
    ANNALS OF HEMATOLOGY, 2006, 85 : 66 - 67
  • [7] Fludarabine with cytarabine followed by reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with poor-risk chronic lymphocytic leukemia
    Marta Krejci
    Michael Doubek
    Yvona Brychtova
    Olga Stehlikova
    Jana Chovancova
    Boris Tichy
    Hana Skuhrova Francova
    Milan Navratil
    Miroslav Tomiska
    Ondrej Horky
    Sarka Pospisilova
    Jiri Mayer
    Annals of Hematology, 2013, 92 : 249 - 254
  • [8] Fludarabine with cytarabine followed by reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with poor-risk chronic lymphocytic leukemia
    Krejci, Marta
    Doubek, Michael
    Brychtova, Yvona
    Stehlikova, Olga
    Chovancova, Jana
    Tichy, Boris
    Francova, Hana Skuhrova
    Navratil, Milan
    Tomiska, Miroslav
    Horky, Ondrej
    Pospisilova, Sarka
    Mayer, Jiri
    ANNALS OF HEMATOLOGY, 2013, 92 (02) : 249 - 254
  • [9] Reduced-intensity conditioning therapy with fludarabine, idarubicin, busulfan and cytarabine for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia and myelodysplastic syndrome
    Gao, Li
    Gao, Lei
    Gong, Yi
    Zhang, Cheng
    Chen, Xing-Hua
    Zhang, Xi
    LEUKEMIA RESEARCH, 2013, 37 (11) : 1482 - 1487
  • [10] Reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia
    Lekakis, Lazaros
    de Lima, Marcos
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (05) : 785 - 798
12345